Showing results (31-40 of 153) with videos related to

Sort By:
Pageof 16
Journal of Acquired Immune Deficiency Syndromes (1999)|March 16, 2013
Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphomaAnthony R Cillo, Amrita Krishnan, Ronald T Mitsuyasu, et al.
Blood|September 25, 2004
Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomasAmrita Krishnan, Arturo Molina, John Zaia, et al.
Clinical Practice and Cases in Emergency Medicine|November 5, 2025
Orbital Compartment Syndrome as a Complication of Blepharoplasty: A Case ReportLev Libet, Jairo Garcia, Lawrence Liu
Leukemia|July 21, 2018
Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myelomaIbrahim Aldoss, Marzia Capelletti, Jihye Park, et al.
Current Opinion in Oncology|July 26, 2022
Selinexor therapy for multiple myeloma and non-Hodgkin lymphomasScott R Goldsmith, Lawrence Liu, Kevin Shiah
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphomaRoberto Rodriguez, Auayporn Nademanee, Nora Ruel, et al.
Research Square|October 4, 2023
Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) TrialEhsan Malek, Jeries Kort, Leland Metheny, et al.
Frontiers in Immunology|May 3, 2024
Designing combination therapies for cancer treatment: application of a mathematical framework combining CAR T-cell immunotherapy and targeted radionuclide therapyVikram Adhikarla, Dennis Awuah, Enrico Caserta, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 18, 2021
Daratumumab Plus Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple MyelomaAndrzej Jakubowiak, Saad Z Usmani, Amrita Krishnan, et al.
Cancers|October 23, 2021
A Mathematical Modeling Approach for Targeted Radionuclide and Chimeric Antigen Receptor T Cell Combination TherapyVikram Adhikarla, Dennis Awuah, Alexander B Brummer, et al.
Pageof 16